Role of Inflammation in Muscle Homeostasis and Myogenesis

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Costamagna, Domiziana ^a,b,c   Costelli, Paola ^a,c   Sampaolesi, Maurilio ^b,c,d   Penna, Fabio ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c Interuniversity Institute of Myology   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; CYTOKINE;

ADULT STEM CELL; CATABOLISM; FIBER; HOMEOSTASIS; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; MUSCLE HOMEOSTASIS; MUSCLE HYPERTROPHY; MUSCLE METABOLISM; NONHUMAN; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SATELLITE CELL; SKELETAL MUSCLE; ANIMAL; AUTOPHAGY; CELL DIFFERENTIATION; CYTOLOGY; HYPERTROPHY; METABOLISM; PATHOLOGY; REGENERATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE SATELLITE CELL; STEM CELL;

ANIMALS; AUTOPHAGY; CELL DIFFERENTIATION; CYTOKINES; HOMEOSTASIS; HUMANS; HYPERTROPHY; INFLAMMATION; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUSCULAR ATROPHY; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84945253835     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/805172     Document Type: Review

References (156)

1. G. Biolo, T. Cederholm, andM. Muscaritoli, "Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia," Clinical Nutrition, vol. 33, no. 5, pp. 737-748, 2014.
2. M. Muscaritoli, S. D. Anker, J. Argilés et al. , "Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) 'cachexia-anorexia in chronic wasting diseases' and ' nutrition in geriatrics'," Clinical Nutrition, vol. 29, no. 2, pp. 154-159, 2010.
3. K. Fearon, F. Strasser, S. D. Anker et al. , "Definition and classification of cancer cachexia: an international consensus," The Lancet Oncology, vol. 12, no. 5, pp. 489-495, 2011.
4. D. Harrington, S. D. Anker, T. P. Chua et al. , "Skeletal muscle function and its relation to exercise tolerance in chronic heart failure," Journal of the American College of Cardiology, vol. 30, no. 7, pp. 1758-1764, 1997.
5. S. Taskin, V. I. Stumpf, J. Bachmann, C. Weber, M. E. Martignoni, and O. Friedrich, "Motor protein function in skeletal abdominal muscle of cachectic cancer patients," Journal of Cellular and Molecular Medicine, vol. 18, no. 1, pp. 69-79, 2014.
6. M. Llano-Diez, G. Renaud, M. Andersson et al. , "Mechanisms underlying ICU muscle wasting and effects of passive mechanical loading," Critical Care, vol. 16, no. 5, article R209, 2012.
7. P. Costelli and F. M. Baccino, "Mechanisms of skeletal muscle depletion in wasting syndromes: Role of ATP-ubiquitindependent proteolysis," Current Opinion in Clinical Nutrition & Metabolic Care, vol. 6, no. 4, pp. 407-412, 2003.
8. F. Penna, F. M. Baccino, and P. Costelli, "Coming back: autophagy in cachexia," Current Opinion in Clinical Nutrition and Metabolic Care, vol. 17, no. 3, pp. 241-246, 2014.
9. P.-O. Hasselgren, C. Wray, and J. Mammen, "Molecular regulation of muscle cachexia: it may be more than the proteasome," Biochemical and Biophysical Research Communications, vol. 290, no. 1, pp. 1-10, 2002.
10. J. Du, X. Wang, C. Miereles et al. , "Activation of caspase-3 is an initial step triggering acceleratedmuscle proteolysis in catabolic conditions," Journal of Clinical Investigation, vol. 113, no. 1, pp. 115-123, 2004.
11. B. J. Krawiec, R. A. Frost, T. C. Vary, L. S. Jefferson, and C. H. Lang, "Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis," The American Journal of Physiology-Endocrinology and Metabolism, vol. 289, no. 6, pp. E969-E980, 2005.
12. E. Masiero, L. Agatea, C. Mammucari et al. , "Autophagy is required to maintain muscle mass," CellMetabolism, vol. 10, no. 6, pp. 507-515, 2009.
13. F. Penna, D. Costamagna, F. Pin et al. , "Autophagic degradation contributes to muscle wasting in cancer cachexia," American Journal of Pathology, vol. 182, no. 4, pp. 1367-1378, 2013.
14. S. Carnio, F. LoVerso,M. A. Baraibar et al. , "Autophagy impairment in muscle induces neuromuscular junction degeneration and precocious aging," Cell Reports, vol. 8, no. 5, pp. 1509-1521, 2014.
15. S. C. Bodine, E. Latres, S. Baumhueter et al. , "Identification of ubiquitin ligases required for skeletal Muscle Atrophy," Science, vol. 294, no. 5547, pp. 1704-1708, 2001.
16. M. D. Gomes, S. H. Lecker, R. T. Jagoe, A. Navon, and A. L. Goldberg, "Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy," Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 25, pp. 14440-14445, 2001.
17. E. Kudryashova, D. Kudryashov, I. Kramerova, and M. J. Spencer, "Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin," Journal of Molecular Biology, vol. 354, no. 2, pp. 413-424, 2005.
18. J. Ye, Y. Zhang, J. Xu, Q. Zhang, and D. Zhu, "FBXO40, a gene encoding a novel muscle-specific F-box protein, is upregulated in denervation-related muscle atrophy," Gene, vol. 404, no. 1-2, pp. 53-60, 2007.
19. J. Shi, L. Luo, J. Eash, C. Ibebunjo, and D. J. Glass, "The SCFFbxo40 complex induces IRS1 ubiquitination in skeletalmuscle, limiting IGF1 signaling," Developmental Cell, vol. 21, no. 5, pp. 835-847, 2011.
20. R. Sartori, E. Schirwis, B. Blaauw et al. , "BMP signaling controls muscle mass," Nature Genetics, vol. 45, no. 11, pp. 1309-1321, 2013.
21. M. Vinciguerra, M. Hede, and N. Rosenthal, "Comments on point:counterpoint: IGF is/is not the major physiological regulator of muscle mass. IGF-1 is a major regulator of muscle mass during growth but not for adult myofiber hypertrophy," Journal ofApplied Physiology, vol. 108, no. 6,pp. 1829-1830, 2010.
22. P. Castets and M. A. Ruëgg, "MTORC1 determines autophagy through ULK1 regulation in skeletal muscle," Autophagy, vol. 9, no. 9, pp. 1435-1437, 2013.
23. M. Sandri, C. Sandri, A. Gilbert et al. , "Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy," Cell, vol. 117, no. 3, pp. 399-412, 2004.
24. C. Mammucari, G. Milan, V. Romanello et al. , "FoxO3 Controls Autophagy in Skeletal Muscle In Vivo," Cell Metabolism, vol. 6, no. 6, pp. 458-471, 2007.
25. S. Lokireddy, C. McFarlane, X. Ge et al. , "Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting," Molecular Endocrinology, vol. 25, no. 11, pp. 1936-1949, 2011.
26. A. U. Trendelenburg, A. Meyer, D. Rohner, J. Boyle, S. Hatakeyama, and D. J. Glass, "Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size,"The American Journal of Physiology-Cell Physiology, vol. 296, no. 6, pp. C1258-C1270, 2009.
27. V. Moresi, A. H. Williams, E. Meadows et al. , "Myogenin and class II HDACs control neurogenicmuscle atrophy by inducing E3 ubiquitin ligases," Cell, vol. 143, no. 1, pp. 35-45, 2010.
28. S. M. Ebert, A. M. Monteys, D. K. Fox et al. , "The transcription factorATF4 promotes skeletalmyofiber atrophy during fasting," Molecular Endocrinology, vol. 24, no. 4, pp. 790-799, 2010.
29. D. K. Fox, S. M. Ebert, K. S. Bongers et al. , "p53 and ATF4 mediate distinct and additive pathways to skeletal muscle atrophy during limb immobilization," The American Journal of Physiology: Endocrinology and Metabolism, vol. 307, no. 3, pp. E245-E261, 2014.
30. J. P. Li, L. Lu, L. J. Wang, F. R. Zhang, andW. F. Shen, "Increased serum levels of S100B are related to the severity of cardiac dysfunction, renal insufficiency and major cardiac events in patients with chronic heart failure," Clinical Biochemistry, vol. 44, no. 12, pp. 984-988, 2011.
31. M. A. Niewczas, T. Gohda, J. Skupien et al. , "Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes," Journal of the American Society of Nephrology, vol. 23, no. 3, pp. 507-515, 2012.
32. B. Seruga, H. Zhang, L. J. Bernstein, and I. F. Tannock, "Cytokines and their relationship to the symptoms and outcome of cancer," Nature Reviews Cancer, vol. 8, no. 11, pp. 887-899, 2008.
33. J. Walston, N. Fedarko, H. Yang et al. , "The physical and biological characterization of a frail mouse model," Journals of Gerontology-Series A Biological Sciences and Medical Sciences, vol. 63, no. 4, pp. 391-398, 2008.
34. B. Wang, G. Yang, X. Liang, M. Zhu, and M. Du, "Grape seed extract prevents skeletal muscle wasting in interleukin 10 knockout mice," BMC Complementary and Alternative Medicine, vol. 14, no. 1, article 162, 2014.
35. W. J. Durham, E. L. Dillon, and M. Sheffield-Moore, "Inflammatory burden and amino acidmetabolism in cancer cachexia," Current Opinion in Clinical Nutrition and Metabolic Care, vol. 12, no. 1, pp. 72-77, 2009.
36. A. Bonetto, T. Aydogdu, N. Kunzevitzky et al. , "STAT3 activation in skeletalmuscle linksmuscle wasting and the acute phase response in cancer cachexia," PLoS ONE, vol. 6, no. 7,Article ID e22538, 2011.
37. G. Biolo, R. Y. Declan Fleming, S. P. Maggi, T. T. Nguyen, D. N. Herndon, and R. R. Wolfe, "Inverse regulation of protein turnover and amino acid transport in skeletal muscle of hypercatabolic patients," Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 7, pp. 3378-3384, 2002.
38. M. Klaude, M. Mori, I. Tjäder, T. Gustafsson, J. Wernerman, and O. Rooyackers, "Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis," Clinical Science, vol. 122, no. 3, pp. 133-142, 2012.
39. N. Johns, N. A. Stephens, and T. Preston, "Muscle protein kinetics in cancer cachexia," Current Opinion in Supportive and Palliative Care, vol. 6, no. 4, pp. 417-423, 2012.
40. M. J. Tisdale, "Catabolic mediators of cancer cachexia," Current Opinion in Supportive and Palliative Care, vol. 2, no. 4, pp. 256-261, 2008.
41. P. Matthys, H. Heremans, G. Opdenakker, and A. Billiau, "Antiinterferon-gamma antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia," European Journal of Cancer and Clinical Oncology, vol. 27, no. 2, pp. 182-187, 1991.
42. P. Costelli, N. Carbo, L. Tessitore et al. , "Tumor necrosis factor-mediates changes in tissue protein turnover in a rat cancer cachexia model," The Journal of Clinical Investigation, vol. 92, no. 6, pp. 2783-2789, 1993.
43. G. Strassmann, M. Fong, C. E. Freter, S. Windsor, F. D'Alessandro, and R. P. Nordan, "Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo," Journal of Clinical Investigation, vol. 92, no. 5, pp. 2152-2159, 1993.
44. A. Mangili, D. H. Murman, A. M. Zampini, and C. A. Wanke, "Nutrition andHIV infection: review ofweight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort," Clinical Infectious Diseases, vol. 42, no. 6, pp. 836-842, 2006.
45. M. Molanouri Shamsi, Z. H. Hassan, R. Gharakhanlou et al. , "Expression of interleukin-15 and inflammatory cytokines in skeletal muscles of STZ-induced diabetic rats: effect of resistance exercise training," Endocrine, vol. 46, no. 1, pp. 60-69, 2014.
46. J. S. W. Lee, T.-W. Auyeung, T. Kwok, E. M. C. Lau, P.-C. Leung, and J. Woo, "Associated factors and health impact of sarcopenia in older Chinese men and women: a cross-sectional study," Gerontology, vol. 53, no. 6, pp. 404-410, 2007.
47. S. A. Reed, E. K. LaVigne, A. K. Jones, D. F. Patterson, and A. L. Schauer, "The aging horse: effects of inflammation onmuscle satellite cells," Journal of Animal Science. In press.
48. D. Cai, J. D. Frantz, N. E. Tawa Jr. et al. , "IKKbeta/NF-kappaB activation causes severe muscle wasting in mice," Cell, vol. 119, no. 2, pp. 285-298, 2004.
49. S. Di Marco, R. Mazroui, P. Dallaire et al. , "NF-B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release,"Molecular and Cellular Biology, vol. 25,no. 15,pp. 6533-6545, 2005.
50. M. G. Rhoads, S. C. Kandarian, F. Pacelli, G. B. Doglietto, and M. Bossola, "Expression of NF-B and IB proteins in skeletal muscle of gastric cancer patients," European Journal of Cancer, vol. 46, no. 1, pp. 191-197, 2010.
51. C. M. Op den Kamp, R. C. Langen, F. J. Snepvangers et al. , "Nuclear transcription factor kappa B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia," The American Journal of Clinical Nutrition, vol. 98, no. 3, pp. 738-748, 2013.
52. W. A. He, E. Berardi, V. M. Cardillo et al. , "NF-B-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia," The Journal of Clinical Investigation, vol. 123, no. 11, pp. 4821-4835, 2013.
53. P. K. Paul, S. K. Gupta, S. Bhatnagar et al. , "Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice," The Journal of Cell Biology, vol. 191, no. 7, pp. 1395-1411, 2010.
54. A. Mittal, S. Bhatnagar, A. Kumar et al. , "The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice," Journal of Cell Biology, vol. 188, no. 6, pp. 833-849, 2010.
55. S. M. Hindi, V. Mishra, S. Bhatnagar et al. , "Regulatory circuitry of TWEAK-Fn14 system and PGC-1alpha in skeletal muscle atrophy program," The FASEB Journal, vol. 28, no. 3, pp. 1398-1411, 2014.
56. R. A. Frost and C. H. Lang, "Regulation of muscle growth by pathogen-associated molecules," Journal of Animal Science, vol. 86, no. 14, supplement, pp. E84-E93, 2008.
57. H. Crossland, D. Constantin-Teodosiu, S. M. Gardiner, D. Constantin, and P. L. Greenhaff, "Apotential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletalmuscle," Journal of Physiology, vol. 586, no. 22, pp. 5589-5600, 2008.
58. Y. Liu, F. Chen, J. Odle et al. , "Fish oil increases muscle protein mass and modulates akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge," Journal of Nutrition, vol. 143, no. 8, pp. 1331-1339, 2013.
59. D. T. Wang, Y. Yin, Y. J. Yang et al. , "Resveratrol prevents TNF-alpha-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12myotubes," International Immunopharmacology, vol. 19, no. 2, pp. 206-213, 2014.
60. J. P. White, M. J. Puppa, S. Gao, S. Sato, S. L. Welle, and J. A. Carson, "Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK," American Journal of Physiology: Endocrinology and Metabolism, vol. 304, no. 10, pp. E1042-E1052, 2013.
61. M. D. Grounds, H. G. Radley, B. L. Gebski, M. A. Bogoyevitch, and T. Shavlakadze, "Implications of cross-talk between tumour necrosis factor and insulin-like growth factor-1 signalling in skeletal muscle," Clinical and Experimental Pharmacology and Physiology, vol. 35, no. 7, pp. 846-851, 2008.
62. K. L. Mcintire, Y. Chen, S. Sood, and R. Rabkin, "Acute uremia suppresses leucine-induced signal transduction in skeletalmuscle," Kidney International, vol. 85, no. 2, pp. 374-382, 2014.
63. A. Mauro, "Satellite cell of skeletal muscle fibers," The Journal of Biophysical and Biochemical Cytology, vol. 9, pp. 493-495, 1961.
64. M. Quattrocelli, M. Cassano, S. Crippa, I. Perini, and M. Sampaolesi, "Cell therapy strategies and improvements for muscular dystrophy," Cell Death and Differentiation, vol. 17, no. 8, pp. 1222-1229, 2010.
65. E. Berardi, D. Annibali, M. Cassano, S. Crippa, and M. Sampaolesi, "Molecular and cell-based therapies for muscle degenerations: a road under construction," Frontiers in Physiology, vol. 5, article 119, 2014.
66. M. Scaal and B. Christ, "Formation and differentiation of the avian dermomyotome," Anatomy and Embryology, vol. 208, no. 6, pp. 411-424, 2004.
67. M. Esner, S. M. Meilhac, F. Relaix, J.-F. Nicolas, G. Cossu, and M. E. Buckingham, "Smooth muscle of the dorsal aorta shares a common clonal origin with skeletal muscle of themyotome," Development, vol. 133, no. 4, pp. 737-749, 2006.
68. H. Yin, F. Price, and M. A. Rudnicki, "Satellite cells and the muscle stem cell niche," Physiological Reviews, vol. 93, no. 1, pp. 23-67, 2013.
69. A. Musarò and L. Barberi, "Isolation and culture of mouse satellite cells," Methods in Molecular Biology, vol. 633, pp. 101-111, 2010.
70. M. J. Conboy, M. Cerletti, A. J. Wagers, and I. M. Conboy, "Immuno-analysis and FACS sorting of adult muscle fiberassociated stem/precursor cells," Methods in Molecular Biology, vol. 621, pp. 165-173, 2010.
71. M. R. Chapman, K. R. Balakrishnan, J. Li et al. , "Sorting single satellite cells from individual myofibers reveals heterogeneity in cell-surface markers and myogenic capacity," Integrative Biology, vol. 5, no. 4, pp. 692-702, 2013.
72. A. Castiglioni, S. Hettmer, M. D. Lynes et al. , "Isolation of progenitors that exhibitmyogenic/osteogenic bipotency in vitro by fluorescence-activated cell sorting fromhuman fetalmuscle," Stem Cell Reports, vol. 2, no. 1, pp. 92-106, 2014.
73. P. Seale, L. A. Sabourin, A. Girgis-Gabardo, A. Mansouri, P. Gruss, and M. A. Rudnicki, "Pax7 is required for the specification of myogenic satellite cells," Cell, vol. 102, no. 6, pp. 777-786, 2000.
74. V. F. Gnocchi, R. B. White, Y. Ono, J. A. Ellis, and P. S. Zammit, "Further characterisation of the molecular signature of quiescent and activated mouse muscle satellite cells," PLoS ONE, vol. 4, no. 4,Article ID e5205, 2009.
75. V. Shinin, B. Gayraud-Morel, D. Gomès, and S. Tajbakhsh, "Asymmetric division and cosegregation of template DNA strands in adult muscle satellite cells," Nature Cell Biology, vol. 8, no. 7, pp. 677-682, 2006.
76. T. A. Partridge, J. E. Morgan, G. R. Coulton, E. P. Hoffman, and L. M. Kunkel, "Conversion of mdx myofibres from dystrophinnegative to-positive by injection of normal myoblasts," Nature, vol. 337, no. 6203, pp. 176-179, 1989.
77. V. Mouly, A. Aamiri, S. Périé et al. , "Myoblast transfer therapy: is there any light at the end of the tunnel" Acta Myologica, vol. 24, no. 2, pp. 128-133, 2005.
78. D. Skuk, B. Roy, M. Goulet et al. , "Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells," Molecular Therapy, vol. 9, no. 3, pp. 475-482, 2004.
79. G. Cossu and M. Sampaolesi, "New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials," Trends in Molecular Medicine, vol. 13, no. 12, pp. 520-526, 2007.
80. N. Motohashi and A. Asakura, "Molecular regulation of muscle satellite cell self-renewal," Journal of Stem Cell Research & Therapy, supplement 11, article e002, 2012.
81. T. Tamaki, Y. Uchiyama, and A. Akatsuka, "Plasticity and physiological role of stem cells derived from skeletal muscle interstitium: contribution to muscle fiber hyperplasia and therapeutic use," Current Pharmaceutical Design, vol. 16, no. 8, pp. 956-967, 2010.
82. T. Tamaki, Y. Okada, Y. Uchiyama et al. , "Synchronized reconstitution of muscle fibers, peripheral nerves and blood vessels by murine skeletal muscle-derived CD34()/45 () cells," Histochemistry and Cell Biology, vol. 128, no. 4, pp. 349-360, 2007.
83. S. M. Cretoiu and L. M. Popescu, "Telocytes revisited," Biomolecular Concepts, vol. 5, no. 5, pp. 353-369, 2014.
84. A. W. B. Joe, L. Yi, A. Natarajan et al. , "Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis," Nature Cell Biology, vol. 12, no. 2, pp. 153-163, 2010.
85. A. Uezumi, S.-I. Fukada, N. Yamamoto, S. Takeda, and K. Tsuchida, "Mesenchymal progenitors distinct fromsatellite cells contribute to ectopic fat cell formation in skeletal muscle," Nature Cell Biology, vol. 12, no. 2, pp. 143-152, 2010.
86. C. Mozzetta, S. Consalvi, V. Saccone et al. , "Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice," EMBO Molecular Medicine, vol. 5, no. 4, pp. 626-639, 2013.
87. S. J. Mathew, J. M. Hansen,A. J. Merrell et al. , "Connective tissue fibroblasts andTcf4 regulatemyogenesis," Development, vol. 138, no. 2, pp. 371-384, 2011.
88. K. J. Mitchell, A. Pannérec, B. Cadot et al. , "Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development," Nature Cell Biology, vol. 12, no. 3, pp. 257-266, 2010.
89. H. Peng and J. Huard, "Muscle-derived stem cells for musculoskeletal tissue regeneration and repair," Transplant Immunology, vol. 12, no. 3-4, pp. 311-319, 2004.
90. K. Zou, H. D. Huntsman, M. C. Valero et al. , "Mesenchymal stem cells augment the adaptive response to eccentric exercise," Medicine & Science in Sports & Exercise, vol. 47, no. 2, pp. 315-325, 2015.
91. G. Cossu and P. Bianco, "Mesoangioblasts-vascular progenitors for extravascular mesodermal tissues," Current Opinion in Genetics and Development, vol. 13, no. 5, pp. 537-542, 2003.
92. L. De Angelis, L. Berghella, M. Coletta et al. , "Skeletalmyogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration," Journal of Cell Biology, vol. 147, no. 4, pp. 869-877, 1999.
93. M. G. Minasi, M. Riminucci, L. De Angelis et al. , "The mesoangioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues," Development, vol. 129, no. 11, pp. 2773-2783, 2002.
94. M. Sampaolesi, Y. Torrente, A. Innocenzi et al. , "Cell therapy of-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts," Science, vol. 301, no. 5632, pp. 487-492, 2003.
95. M. Sampaolesi, S. Blot, G. D'Antona et al. , "Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs," Nature, vol. 444, no. 7119, pp. 574-579, 2006.
96. A. Dellavalle, M. Sampaolesi, R. Tonlorenzi et al. , "Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells," Nature Cell Biology, vol. 9, no. 3,pp. 255-267, 2007.
97. R. Tonlorenzi, A. Dellavalle, E. Schnapp, G. Cossu, and M. Sampaolesi, "Isolation and characterization of mesoangioblasts frommouse, dog, and human tissues," Current Protocols in Stem Cell Biology, chapter 2, unit 2B. 1, 2007.
98. M. Quattrocelli, G. Palazzolo, I. Perini, S. Crippa, M. Cassano, andM. Sampaolesi, "Mouse and humanmesoangioblasts: isolation and characterization from adult skeletal muscles," Methods in Molecular Biology, vol. 798, pp. 65-76, 2012.
99. M. Quattrocelli, D. Costamagna, G. Giacomazzi, J. Camps, and M. Sampaolesi, "Notch signaling regulates myogenic regenerative capacity ofmurine and humanmesoangioblasts," Cell Death and Disease, vol. 5, no. 10, Article IDe1448, 2014.
100. M. Crisan, S. Yap, L. Casteilla et al. , "A perivascular origin for mesenchymal stem cells in multiple human organs," Cell Stem Cell, vol. 3, no. 3, pp. 301-313, 2008.
101. A. I. Caplan, "All MSCs are pericytes" Cell Stem Cell, vol. 3, no. 3, pp. 229-230, 2008.
102. V. D. Roobrouck, C. Clavel, S. A. Jacobs et al. , "Differentiation potential of human postnatalmesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions," Stem Cells, vol. 29, no. 5, pp. 871-882, 2011.
103. E. Linder, V. P. Lehto, and S. Stenman, "Activation of complement by cytoskeletal intermediate filaments," Nature, vol. 278, no. 5700, pp. 176-178, 1979.
104. A. Rubartelli and M. T. Lotze, "Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox," Trends in Immunology, vol. 28,no. 10, pp. 429-436, 2007.
105. H. X. Nguyen, A. J. Lusis, and J. G. Tidball, "Null mutation of myeloperoxidase in mice prevents mechanical activation of neutrophil lysis of muscle cell membranes in vitro and in vivo," The Journal of Physiology, vol. 565, no. 2, pp. 403-413, 2005.
106. L. Arnold, A. Henry, F. Poron et al. , "Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis," The Journal of Experimental Medicine, vol. 204, no. 5, pp. 1057-1069, 2007.
107. T. J. Hawke andD. J. Garry, "Myogenic satellite cells: physiology to molecular biology," Journal of Applied Physiology, vol. 91, no. 2, pp. 534-551, 2001.
108. G. L. Warren, T. Hulderman,N. Jensen et al. , "Physiological role of tumor necrosis factor alpha in traumatic muscle injury," The FASEB Journal, vol. 16, no. 12, pp. 1630-1632, 2002.
109. J. E. Heredia, L. Mukundan, F. M. Chen et al. , "Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration," Cell, vol. 153, no. 2, pp. 376-388, 2013.
110. V. Horsley, K. M. Jansen, S. T. Mills, andG. K. Pavlath, "IL-4 acts as a myoblast recruitment factor during mammalian muscle growth," Cell, vol. 113, no. 4, pp. 483-494, 2003.
111. C. Chiristov, F. Chrétien, R. Abou-Khalil et al. , "Muscle satellite cells and endothelial cells: close neighbors and privileged partners," Molecular Biology of the Cell, vol. 18, no. 4, pp. 1397-1409, 2007.
112. B. Chazaud, C. Sonnet, P. Lafuste et al. , "Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth,"The Journal of Cell Biology, vol. 163, no. 5, pp. 1133-1143, 2003.
113. B. A. St. Pierre and J. G. Tidball, "Differential response of macrophage subpopulations to soleusmuscle reloading after rat hindlimb suspension," Journal of Applied Physiology, vol. 77, no. 1, pp. 290-297, 1994.
114. M. Bencze, E. Negroni, D. Vallese et al. , "Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation,"MolecularTherapy, vol. 20,no. 11,pp. 2168-2179, 2012.
115. M. Segawa, S.-I. Fukada, Y. Yamamoto et al. , "Suppression of macrophage functions impairs skeletal muscle regeneration with severe fibrosis," Experimental Cell Research, vol. 314, no. 17, pp. 3232-3244, 2008.
116. E. Perdiguero, P. Sousa-Victor,V. Ruiz-Bonilla et al. , "p38/MKP-1-regulated AKT coordinates macrophage transitions and resolution of inflammation during tissue repair," The Journal of Cell Biology, vol. 195, no. 2, pp. 307-322, 2011.
117. B. Deng, J. Wen, Y. Ding et al. , "Functional analysis of pigmyostatin gene promoter with some adipogenesis-andmyogenesisrelated factors," Molecular and Cellular Biochemistry, vol. 363, no. 1-2, pp. 291-299, 2012.
118. L. Bosurgi, G. Corna, M. Vezzoli et al. , "Transplanted mesoangioblasts require macrophage IL-10 for survival in a mouse model of muscle injury," The Journal of Immunology, vol. 188, no. 12, pp. 6267-6277, 2012.
119. N. Bakkar, J. Wang, K. J. Ladner et al. , "IKK/NF-B regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis," Journal of Cell Biology, vol. 180, no. 4, pp. 787-802, 2008.
120. D. C. Guttridge, M. W. Mayo, L. V. Madrid, C.-Y. Wang, and A. S. J. Baldwin, "NF-kappaB-induced loss ofMyoD messenger RNA: possible role in muscle decay and cachexia," Science, vol. 289, no. 5488, pp. 2363-2365, 2000.
121. A. U. Trendelenburg, A. Meyer, C. Jacobi, J. N. Feige, and D. J. Glass, "TAK-1/p38/nNFB signaling inhibitsmyoblast differentiation by increasing levels of Activin A," Skeletal Muscle, vol. 2, no. 1, article 3, 2012.
122. E. Sierra-Filardi, A. Puig-Kröger, F. J. Blanco et al. , "Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of antiinflammatory macrophage markers," Blood, vol. 117, no. 19, pp. 5092-5101, 2011.
123. A. E. Kalovidouris, Z. Plotkin, and D. Graesser, "Interferon-inhibits proliferation, differentiation, and creatine kinase activity of cultured human muscle cells. II. A possible role in myositis," Journal of Rheumatology, vol. 20,no. 10,pp. 1718-1723, 1993.
124. S. A. Villalta, B. Deng, C. Rinaldi, M. Wehling-Henricks, and J. G. Tidball, "IFN-promotes muscle damage in the mdx mouse model of duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibitingmuscle cell proliferation," Journal of Immunology, vol. 187, no. 10, pp. 5419-5428, 2011.
125. P. Londhe and J. K. Davie, "Gamma interferon modulates myogenesis through the major histocompatibility complex class II transactivator, CIITA,"Molecular and Cellular Biology, vol. 31, no. 14, pp. 2854-2866, 2011.
126. N. Mathur and B. K. Pedersen, "Exercise as a mean to control low-grade systemic inflammation," Mediators of Inflammation, vol. 2008, Article ID109502, 6 pages, 2008.
127. C. Broholm, O. H. Mortensen, S. Nielsen et al. , "Exercise induces expression of leukaemia inhibitory factor in human skeletal muscle," The Journal of Physiology, vol. 586, no. 8, pp. 2195-2201, 2008.
128. L. S. Quinn, B. G. Anderson, L. Strait-Bodey, A. M. Stroud, and J. M. Argués, "Oversecretion of interleukin-15 fromskeletal muscle reduces adiposity,"TheAmerican Journal of Physiology-Endocrinology and Metabolism, vol. 296, no. 1, pp. E191-E202, 2009.
129. M. M. Seldin and G. W. Wong, "Regulation of tissue crosstalk by skeletal muscle-derived myonectin and other myokines," Adipocyte, vol. 1, no. 4, pp. 200-202, 2014.
130. B. K. Pedersen, "Muscular interleukin-6 and its role as an energy sensor," Medicine & Science in Sports & Exercise, vol. 44, no. 3, pp. 392-396, 2012.
131. P. Boström, J. Wu, M. P. Jedrychowski et al. , "A PGC1-alphadependent myokine that drives brown-fat-like development of white fat and thermogenesis," Nature, vol. 481, no. 7382, pp. 463-468, 2012.
132. O. H. Mortensen, K. Andersen, C. Fischer et al. , "Calprotectin is released from human skeletal muscle tissue during exercise," The Journal of Physiology, vol. 586, no. 14, pp. 3551-3562, 2008.
133. L. Pedersen, C. H. Olsen, B. K. Pedersen, and P. Hojman, "Muscle-derived expression of the chemokine CXCL1 attenuates diet-induced obesity and improves fatty acid oxidation in the muscle," The American Journal of Physiology-Endocrinology and Metabolism, vol. 302, no. 7, pp. E831-E840, 2012.
134. A. Steensberg, C. P. Fischer, C. Keller, K. Møller, and B. K. Pedersen, "IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans," American Journal of Physiology-Endocrinology and Metabolism, vol. 285, no. 2, pp. E433-E437, 2003.
135. S. Hodgetts, H. Radley, M. Davies, and M. D. Grounds, "Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice," Neuromuscular Disorders, vol. 16, no. 9-10, pp. 591-602, 2006.
136. W. A. Irwin, N. Bergamin, P. Sabatelli et al. , "Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency," Nature Genetics, vol. 35, no. 4, pp. 367-371, 2003.
137. P. Grumati, L. Coletto, P. Sabatelli et al. , "Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration," Nature Medicine, vol. 16, no. 11, pp. 1313-1320, 2010.
138. F. Gattazzo, S. Molon, V. Morbidoni et al. , "Cyclosporin a promotes in vivo myogenic response in collagen VI-deficient myopathic mice," Frontiers in Aging Neuroscience, vol. 6, article 244, 2014.
139. A. L. Serrano, C. J. Mann, B. Vidal, E. Ardite, E. Perdiguero, and P. Muñoz-Cánoves, "Cellular and molecular mechanisms regulating fibrosis in skeletal muscle repair and disease," Current Topics in Developmental Biology, vol. 96, pp. 167-201, 2011.
140. D. Palacios, C. Mozzetta, S. Consalvi et al. , "TNF/p38/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control ofmuscle regeneration," Cell Stem Cell, vol. 7, no. 4, pp. 455-469, 2010.
141. F. Penna, D. Costamagna, A. Fanzani, G. Bonelli, F. M. Baccino, and P. Costelli, "Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition," PLoS ONE, vol. 5, no. 10, Article IDe13604, 2010.
142. S. Ramamoorthy, M. Donohue, andM. Buck, "Decreased Jun-D and myogenin expression in muscle wasting of human cachexia," American Journal of Physiology-Endocrinology and Metabolism, vol. 297, no. 2, pp. E392-E401, 2009.
143. A. Uezumi, T. Ito, D. Morikawa et al. , "Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle," Journal of Cell Science, vol. 124, no. 21, pp. 3654-3664, 2011.
144. V. Saccone, S. Consalvi, L. Giordani et al. , "HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles," Genes&Development, vol. 28,no. 8, pp. 841-857, 2014.
145. P. Sousa-Victor, S. Gutarra, L. Garcá-Prat et al. , "Geriatric muscle stem cells switch reversible quiescence into senescence," Nature, vol. 506, no. 7488, pp. 316-321, 2014.
146. B. M. Carlson and J. A. Faulkner, "Muscle transplantation between young and old rats: Age of host determines recovery," The American Journal of Physiology-Cell Physiology, vol. 256, no. 6, pp. C1262-C1266, 1989.
147. G. Goldspink, K. Fernandes, P. E. Williams, and D. J. Wells, "Age-related changes in collagen gene expression in themuscles of mdx dystrophic and normal mice," Neuromuscular Disorders, vol. 4, no. 3, pp. 183-191, 1994.
148. L. Barberi, B. M. Scicchitano,M. de Rossi et al. , "Age-dependent alteration in muscle regeneration: the critical role of tissue niche," Biogerontology, vol. 14, no. 3, pp. 273-292, 2013.
149. A. S. Brack,M. J. Conboy, S. Roy et al. , "IncreasedWnt signaling during aging alters muscle stem cell fate and increases fibrosis," Science, vol. 317, no. 5839, pp. 807-810, 2007.
150. F. D. Price, J. von Maltzahn, C. F. Bentzinger et al. , "Inhibition of JAK-STAT signaling stimulates adult satellite cell function," Nature Medicine, vol. 20, no. 10, pp. 1174-1181, 2014.
151. T.-S. Jang, E.-J. Lee, J.-H. Jo et al. , "Fibrous membrane of nano-hybrid poly-L-lactic acid/silica xerogel for guided bone regeneration," Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol. 100, no. 2, pp. 321-330, 2012.
152. D. A. Harrison, "The JAK/STAT pathway," Cold Spring Harbor Perspectives in Biology, vol. 4, no. 3, 2012.
153. M. T. Tierney, T. Aydogdu, D. Sala et al. , "STAT3 signaling controls satellite cell expansion and skeletal muscle repair," Nature Medicine, vol. 20, no. 10, pp. 1182-1186, 2014.
154. K. Fearon, J. Arends, and V. Baracos, "Understanding the mechanisms and treatment options in cancer cachexia," Nature Reviews Clinical Oncology, vol. 10, no. 2, pp. 90-99, 2013.
155. K. L. Timmerman, M. G. Flynn, P. M. Coen, M. M. Markofski, and B. D. Pence, "Exercise training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the antiinflammatory influence of exercise" Journal of Leukocyte Biology, vol. 84, no. 5, pp. 1271-1278, 2008.
156. M. K. Handzlik, A. J. Shaw, M. Dungey, N. C. Bishop, and M. Gleeson, "The influence of exercise training status on antigen-stimulated IL-10 production inwhole blood culture and numbers of circulating regulatory T cells," European Journal of Applied Physiology, vol. 113, no. 7, pp. 1839-1848, 2013.